Cargando...

Therapeutic Potential of Fluoxetine in Neurological Disorders

The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Main Authors: Mostert, Jop P., Koch, Marcus W., Heerings, Marco, Heersema, Dorothea J., De Keyser, Jacques
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Inc 2008
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/
https://ncbi.nlm.nih.gov/pubmed/18482027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!